A limited number of Allscripts services went down due to a ransomware incident. The company is investigating the incident and working to restore the systems. Some users expressed frustration on Twitter, with one specifically mentioning being unable to access patient data. Allscripts stated that there is currently no evidence of data being removed from their systems.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
